Dr. Suzanne Garland
Royal Women's Hospital, Australia
Dr. Garland is an internationally recognized clinical microbiologist and sexual health physician, with expertise in infectious diseases as they pertain to reproductive health and the neonate. She currently leads an HPV vaccine effectiveness trial (VACCINE) in Australia which will be informative globally. Prof Garland has a keen interest in probiotics in neonates and led the world’s largest RCT the results of which have changed neonatal practice globally. She has also embraced new technologies utilizing e-health as novel recruitment methods as well is interventions in a young female health initiative (YFHI). She is a regular Advisor to the WHO, largely in the area of sexually transmitted infection diagnosis, for prophylactic HPV vaccines, as well as international standards for HPV DNA assays. She has published extensively in more than 460 peer-reviewed journals, as well as being invited to deliver plenary presentations at national and international meetings. She is the Inaugural and Past President of the newly formed society, AOGIN. In 2018 she was awarded the prestigious Officer of the Order of Australia [AO] and also elected Vice president of IPVS.